←
EC Action Network4,046 posts
EC Action Network avatar

EC Action Network

@ECActionNetwork

ECAN saves lives through public awareness of the link between heartburn and cancer and advocacy for better tools to fight EC! Esophageal Cancer Ends Here!

◷ Joined October 2010▧ 914 Photos and videos
Nicholas Hornstein avatar
⟳ EC Action Network retweeted
Nicholas Hornstein@GIMedOnc·16 Oct 2025

Holy smokes, MATTERHORN hits OS! 🏔️🔥 We’ve been waiting for this one. After FLOT became standard for resectable gastric and GEJ adenocarcinoma, everyone wondered if adding immunotherapy could move the bar. Earlier this year, MATTERHORN showed a big EFS win for DFLOT, along with higher pCR and MPR rates, but the question was, would OS follow (and yes, maybe I was doubting this)? Now we have the answer: 🧬 OS HR 0.78 (95% CI 0.63–0.96, p=0.021) A clean, statistically significant win. 💪 Benefit seen across PD-L1 subgroups (TAP <1% HR 0.79; TAP ≥1% HR 0.79). 🧫 More nodal downstaging: ypN– 58% vs 45%, OR 1.72 (1.30–2.27). ⏱️ EFS improved in those with pCR (HR 0.29) and MPR (HR 0.32). Takeaway: Perioperative chemoimmunotherapy is here for gastric and GEJ adenocarcinoma. MATTERHORN delivers the OS confirmation we needed and cements DFLOT as standard of care (we can argue about PD1 +/- later). @OncoAlert @GutOncLab #ESMO25 🧬💥

EC Action Network avatar
⟳ EC Action Network retweeted
EC Action Network@ECActionNetwork·3 Oct 2025

👉🏼 Register now for our webinar on Friday, 10/10 at 3 pm Eastern us02web.zoom.us/webinar/regi… Research now supports immunotherapy for Esophageal & GE Junction Adenocarcinoma BEFORE surgery for patients who are eligible for esophagectomy. Learn what it means for patients.

Post attachment
Memorial Sloan Kettering Cancer Center avatar
⟳ EC Action Network retweeted
Memorial Sloan Kettering Cancer Center@MSKCancerCenter·13 Aug 2025

According to a study co-led by researchers at MSK and published in @NatureMedicine, a new vaccine shows encouraging early results as a potential ready-made treatment for patients with pancreatic or colorectal cancer. Unlike individualized cancer vaccines, which are tailored to each patient, ready-made vaccines can be mass-produced and stored for immediate use. The vaccine, ELI-002 2P, targets tumors with mutations (or changes) in the KRAS gene, a driving force in many cancers, and is given after surgery to prevent or delay a return of cancer. “Having this type of vaccine would make it easier, faster, and less expensive to treat a larger number of patients,” says medical oncologist and pancreatic cancer specialist @EileenMOReilly, who co-led the trial. “This gives hope for people with pancreatic and colorectal cancer who have been out of effective treatments when their disease returns.” Learn more: bit.ly/45PS4ti

Post attachment
EC Action Network avatar
EC Action Network@ECActionNetwork·14 Jul 2025

🥊 Wear Your Support for the Fight to End Esophageal Cancer on Your Sleeve - or Visor - or Lawn Sign! 🛍️ BIG SAVINGS - at least 50% off EVERYTHING! 👉🏼 BuyPeriwinkle.org 📦 FREE SHIPPING on orders of $100 or more 🚛 We are moving: YOU GET GREAT DEALS ➡️ We get lighter boxes

Post attachment
Lucid Diagnostics avatar
⟳ EC Action Network retweeted
Lucid Diagnostics@LucidDiag·26 Jun 2025

“Digestive cancers, especially esophageal cancer, are among the deadliest, yet gastrointestinal esophageal reflux disease (GERD) is a common, treatable precursor,” Dr. Kenneth Chang said. “This makes esophageal cancer highly preventable. With the right strategy and implementation, we could make Orange County an esophageal cancer-free zone.” Read the @USATODAY @hoaghealth story: usatoday.com/story/sponsor-s…

Post attachment